Three H9N2 lineages are circulating at once in Bangladesh poultry

Bangladesh’s endemic H9N2 avian influenza population is moving along two tracks at the same time. The viruses are splitting genetically while remaining, for now, largely stable in antigenic behavior. That combination is clinically important for poultry health because it can preserve vaccine relevance even as the virus keeps reshuffling its genome in the field.

Phylogenetic analysis of 219 sampled sequences identified three genetically distinct monophyletic haemagglutinin, or HA, G-lineage subgroups. Each subgroup carried its own amino acid substitutions, creating clear genetic separation at the HA level. Neuraminidase, by contrast, showed comparable genetic diversity without forming the same clean phylogenetic clusters, a pattern that fits with ongoing reassortment rather than simple linear drift.

One practical consequence stands out immediately: the viral population is not traveling as a single uniform lineage. In a setting where poultry movement is dense and live bird markets are central nodes of animal exchange, that fragmentation creates repeated chances for distinct viruses to meet, swap segments, and persist side by side.

Reassortment is happening in plain sight

A dual-metric comparison of paired HA and NA phylogenies identified 20 putative reassortant H9N2 viruses. Reassortment is not a cosmetic genetic event. In influenza, it can rapidly combine gene segments from different parental viruses, changing replication behavior, host adaptation, and sometimes virulence or transmissibility without requiring a wholesale rewrite of the surface proteins.

Geographic structure was present in the dataset, but it did not confine each subgroup to a single region. All three HA subgroups co-circulated across multiple areas, and some live bird markets contained representatives of all three groups at the same time. Those markets therefore appear to be more than simple points of sale. They function as biological mixing spaces where viruses from different poultry sources can enter the same host population and exchange genomic segments.

The finding matters because geographic separation does not seem to provide a strong barrier once poultry products and live birds enter the market network. Even when a subgroup emerges in one location, it does not remain isolated for long. The result is a circulating pool of related but genetically distinct viruses that can be sampled from different regions without losing their shared lineage identity.

Antigenic stability persists despite genetic diversification

Despite the genetic churn, the viruses remained antigenically similar in haemagglutination inhibition and virus neutralisation assays. In plain terms, the immune system still recognized them in broadly comparable ways. For vaccine strategy, that is the most consequential result in the study, because surface-protein changes are what typically erode protection first.

The antigenic findings also explain why a highly diverse genomic picture has not yet translated into equally divergent serologic behavior. Influenza evolution does not always move in lockstep across all domains of the virus. The HA protein can accumulate substitutions that preserve major antigenic features while still marking distinct genetic branches, especially when selection pressure favors maintenance of receptor binding and transmissibility in poultry rather than radical immune escape.

A single representative strain from one subgroup did break that pattern partially. It induced significantly lower homologous and heterologous antibody titres, suggesting reduced immunogenicity relative to the others. That is the sharpest signal in the study and the one with the most direct vaccine relevance, because a virus that generates weaker antibody responses may be harder to contain even when it remains antigenically close to circulating strains.

The antibody data do not overturn the broader conclusion, but they do narrow it. Conserved antigenic phenotype does not mean every isolate behaves identically in an immune assay. Small shifts in immunogenicity can still matter in flock-level protection, especially in environments where repeated exposure, suboptimal coverage, and constant viral recycling can expose gaps in immune pressure.

Poultry markets remain the engine of viral mixing

The molecular pattern points back to the poultry production and marketing system. Live bird markets are the most plausible venue for the observed co-circulation and reassortment, because they bring together birds from different geographic sources in close proximity and allow infected animals to mix with susceptible ones. In that setting, the virus gains both evolutionary opportunity and epidemiologic reach.

For surveillance, the message is straightforward. Genetic monitoring alone will not fully predict antigenic change in Bangladeshi H9N2 viruses, and antigenic testing alone will miss the scale of reassortment now taking place. The two approaches need to be read together if vaccine strain selection is going to keep pace with the field population.

The study also reinforces why poultry influenza remains a zoonotic concern even when antigenic drift appears modest. A virus that preserves its surface phenotype can continue to circulate efficiently in birds while accumulating internal genetic changes that support persistence. In that context, the main public health challenge is not a sudden antigenic rupture but the slow, repeated expansion of a diversified reservoir that remains close enough to current vaccines to evade complacency, yet dynamic enough to keep generating new reassortant forms.

These findings come from a preprint and have not yet undergone peer review, so the genomic and serologic conclusions should be interpreted with the usual caution reserved for early-stage reports. Even so, the dataset is large enough to show a clear pattern: H9N2 avian influenza in Bangladesh is genetically fragmented, reassorting repeatedly, and still antigenically compact. The unresolved question is whether continued market-driven mixing will eventually push one of these co-circulating subgroups beyond the current serologic boundaries.


Reporting by Dr. A.R. Athira, MBBS for Medicine World Foundation, with additional data provided by bioRxiv (Biomedical Preprints).